Dr. Véronique Lecault is a co-founder of AbCellera and has served in various positions since November 2012, as a member of the Board of Directors since August 2018, as Chief Operating Officer from January 2019 to February 2025, and as Chief Technology Officer since February 2025. She co-invented the high-throughput microfluidic platform that is now a core part of AbCellera's antibody-discovery technology and oversees the company's process development, clinical manufacturing, quality, engineering, data science and infrastructure functions. She holds a B.A.Sc. in Chemical Engineering / Honours B.Sc. in Biochemistry (Biotechnology) from the University of Ottawa and a Ph.D. in Chemical and Biological Engineering from the University of British Columbia.